Mr. Bob Rai reports

VANC PHARMACEUTICALS APPOINTS JOHN PAPASTERGIOU TO BOARD OF DIRECTORS

Vanc Pharmaceuticals Inc. has appointed Professor John Papastergiou to its board of directors.

Prof. Papastergiou brings a unique mix of business acumen, clinical research experience and award-winning pharmacy practice to the board. His groundbreaking work in point-of-care testing has contributed to the expansion of the community pharmacist's role to include screening and monitoring for chronic diseases and other ailments, which all strongly supports Vanc's corporate strategy.

"Vanc's mission to bring point-of-care technologies to community pharmacy is aligned with where I believe the future of the industry, and health care in general, is headed," commented Prof. Papastergiou. "I strongly believe that pharmacists can be instrumental in the delivery of high-quality and cost-effective clinical services. Pro-actively screening and monitoring patients dealing with a variety of health concerns is a perfect example that."

Much of Prof. Papastergiou's research has focused on validating the effectiveness of community pharmacy screening programs and the positive health outcomes they can provide.

"We are privileged to have such a leading advocate of community pharmacy join our board of directors," stated Bob Rai, chief executive officer. "Both his research and direct experience operationalizing point-of-care programs will guide our strategy as we begin to implement the HealthTab system and other point-of-care technologies."

David Hall, chairman of the board of directors, commented: "The addition of a community pharmacy leader, such as John Papastergiou, to our board of directors further validates our belief in the growing importance of community pharmacy in keeping Canadians healthy. By pairing innovative technology with high-quality generic and OTC products, we aim to be at the forefront of where the industry is headed and to help shape the future of pharmacy and health care in Canada."

Vanc has granted 150,000 stock options at 15 cents for a period of five years to a director of the company subject to regulatory provisions.

About Vanc Pharmaceuticals Inc.

Vanc Pharmaceuticals aims to become the partner of choice for forward-thinking pharmacies across Canada. Vanc is growing beyond generics to provide pharmacists with innovative, value-added products and services.

We seek Safe Harbor.